Earnings report: Novo Nordisk cashes in on weight loss drug fever with better-than-expected results
Novo Nordisk(NVO) Invezz·2024-05-02 06:23This morning, pharmaceuticals company Novo Nordisk reported triumphant Q1 2024 financial results before markets opened.Are you looking for signals & alerts from pro-traders? Sign-up to Invezz Signals™ for FREE. Takes 2 mins.One of the more memorable highlights was certainly the fact that Novo Nordisk’s sales increased by 22% in Danish kroner (by 24% at constant exchange rates) to DKK 65.3 billion for the period. Profits up by over a quarterCopy link to sectionMeanwhile, operating profit increased by 27% in ...